PET studies of dopamine receptor distribution using [18F]fluoroethylspiperone: findings in disorders related to the dopaminergic system
- 1 October 1990
- journal article
- research article
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 81 (3) , 195-213
- https://doi.org/10.1007/bf01245042
Abstract
PET studies of dopamine D2-receptor binding were performed in thirty patients with various disorders related to the dopaminergic system and in six healthy controls. Uptake of [18F]fluoroethylspiperone in caudate over three hours was analyzed in terms of several indices of receptor binding: caudateto-cerebellum activity ratio, concentration of ligand as percentage of injected dose, caudate-to-blood radioactivity ratio, slope of tracer uptake curves, binding potential, kinetic constants of a three compartment model. In 14 patients brain glucose metabolism was also measured. Data on medicated patients demonstrate that the average values of most of the above parameters indicate the decreased number of available D2-receptors whereby, besides an age dependent decline, the caudate-to-cerebellum ratio affords the relatively best distinction among diagnostic groups. In individual cases, large variability among subjects permits only the classification of severe pathologies. Morphological damage and neuronal loss in the striatum may also cause abnormal low values both for the indices of receptor binding and for glucose consumption, thus providing a possible pathogenetic link between receptor dysfunction and impaired energy metabolism.This publication has 32 references indexed in Scilit:
- No-carrier-added 3-(2′-[18F]fluoroethyl)spiperone, a new dopamine receptor-binding tracer for positron emission tomographyInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1986
- 3-N-(2-[18F]-fluoroethyl)-spiperone: A novel ligand for cerebral dopamine receptor studies with petLife Sciences, 1986
- Loss of Striatal [76Br]Bromospiperone Binding Sites Demonstrated by Positron Tomography in Progressive Supranuclear PalsyJournal of Cerebral Blood Flow & Metabolism, 1986
- Strategies for in vivo Measurement of Receptor Binding Using Positron Emission TomographyJournal of Cerebral Blood Flow & Metabolism, 1986
- Syntheses and D2 receptor affinities of derivatives of spiperone containing aliphatic halogensApplied Radiation and Isotopes, 1986
- Estimation of Local Cerebral Glucose Utilization by Positron Emission Tomography of [18F]2-Fluoro-2-Deoxy-D-Glucose: A Critical Appraisal of Optimization ProceduresJournal of Cerebral Blood Flow & Metabolism, 1985
- Performance Study of the PC-384 Positron Camera System for Emission Tomography of the BrainJournal of Computer Assisted Tomography, 1984
- Imaging Dopamine Receptors in the Human Brain by Positron TomographyScience, 1983
- Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of methodAnnals of Neurology, 1979
- THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT1Journal of Neurochemistry, 1977